Effects of luteinizing hormone and human chorionic gonadotropin on corpus luteum cells in a spheroid cell culture system

Molecular Reproduction and Development

Volumn 72, Issue 1, 2005, Pages 98-104

  Walz, A ^a   Keck, C ^a   Weber, H ^b   Kissel, C ^a   Pietrowski, D ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b TUMOR BIOLOGY CENTER   (Germany)

Author keywords

Corpus luteum; Granulosa cells; Human chorionic gonadotropin; Luteinizing hormone; Spheroids

Indexed keywords

CHORIONIC GONADOTROPIN; G PROTEIN COUPLED RECEPTOR; LUTEINIZING HORMONE; VASCULOTROPIN A;

ARTICLE; CELL CULTURE; CELL MIGRATION; CORPUS LUTEUM FUNCTION; ENDOTHELIUM CELL; GRANULOSA CELL; HORMONAL REGULATION; HUMAN; HUMAN CELL; LIFESPAN; LUTEAL CELL; PRIORITY JOURNAL; SPHEROID CELL; SPROUTING; THECA CELL; VASCULARIZATION;

CELLS, CULTURED; CHORIONIC GONADOTROPIN; CORPUS LUTEUM; FEMALE; GRANULOSA CELLS; HUMANS; LUTEINIZING HORMONE;

EID: 22644435958     PISSN: 1040452X     EISSN: None     Source Type: Journal    
DOI: 10.1002/mrd.20325     Document Type: Article

References (41)

1. Abell A, Liu X, Segaloff DL. 1996. Deletions of portions of the extracellular loops of the lutropin/choriogonadotropin receptor decrease the binding affinity for ovine luteinizing hormone, but not human choriogonadotropin, by preventing the formation of mature cell surface receptor. J Biol Chem 271:4518-4527.
2. Abell AN, McCormick DJ, Segaloff DL. 1998. Certain activating mutations within helix 6 of the human luteinizing hormone receptor may be explained by alterations that allow transmembrane regions to activate Gs. Mol Endocrinol 12:1857-1869.
3. Antczak M. 2001. Possible ramifications of the identification of ovarian follicular granulosa cells as specialized endothelial-like cells: a speculative treatise. Reprod Biomed Online 2:188-197.
4. Antczak M, Van Blerkom J. 2000. The vascular character of ovarian follicular granulosa cells: Phenotypic and functional evidence for an endothelial-like cell population. Hum Reprod 15:2306-2318.
5. Bourdage RJ, Fitz TA, Niswender GD. 1984. Differential steroidogenic responses of ovine luteal cells to ovine luteinizing hormone and human chorionic gonadotropin. Proc Soc Exp Biol Med 175:483-486.
6. Bukovsky A, Chen TT, Wimalasena J, Caudle MR. 1993. Cellular localization of luteinizing hormone receptor immunoreactivity in the ovaries of immature, gonadotropin-primed, and normal cycling rats. Biol Reprod 48:1367-1382.
7. Bukovsky A, Indrapichate K, Fujiwara H, Cekanova M, Ayala ME, Dominguez R, Caudle MR, Wimalsena J, Elder RF, Copas P, Foster JS, Fernando RI, Henley DC, Upadhyaya NB. 2003. Multiple luteinizing hormone receptor (LHR) protein variants, interspecies reactivity of anti-LHR mAb clone 3B5, subcellular localization of LHR in human placenta, pelvic floor and brain, and possible role for LHR in the development of abnormal pregnancy, pelvic floor disorders and Alzheimer's disease. Reprod Biol Endocrinol 1:46.
8. Chinoy MR, Graybill MM, Miller SA, Lang CM, Kauffman GL. 2002. Angiopoietin-1 and VEGF in vascular development and angiogenesis in hypoplastic lungs. Am J Physiol Lung Cell Mol Physiol 283:L60-L66.
9. Cunningham SA, Tran TM, Arrate MP, Brock TA. 1999. Characterization of vascular endothelial cell growth factor interactions with the kinase insert domain-containing receptor tyrosine kinase. A real time kinetic study. J Biol Chem 274:18421-18427.
10. Davis JS, Rueda BR. 2002. The corpus luteum: An ovarian structure with maternal instincts and suicidal tendencies. Front Biosci 7:d1949-d1978.
11. Davis JS, Rueda BR. 2003a. Recent advancements in corpus luteum development, function, maintenance and regression: Forum introduction. Reprod Biol Endocrinol 1:86.
12. Davis JS, Rueda BR, Spanel-Borowski K. 2003b. Microvascular endothelial cells of the corpus luteum. Reprod Biol Endocrinol 1:89.
13. Eberhard A, Kahlert S, Goede V, Hemmerlein B, Plate KH, Augustin HG. 2000. Heterogeneity of angiogenesis and blood vessel maturation in human tumors: Implications for antiangiogenic tumor therapies. Cancer Res 60:1388-1393.
14. Flamme I, Frolich T, Risau W. 1997. Molecular mechanisms of vasculogenesis and embryonic angiogenesis. J Cell Physiol 173:206-210.
15. Fraser HM, Dickson SE, Lunn SF, Wulff C, Morris KD, Carroll VA, Bicknell R. 2000. Suppression of luteal angiogenesis in the primate after neutralization of vascular endothelial growth factor. Endocrinology 141:995-1000.
16. Funaro A, Sapino A, Ferranti B, Horenstein AL, Castellano I, Bagni B, Garotta G, Malavasi F. 2003. Functional, structural, and distribution analysis of the chorionic gonadotropin receptor using murine monoclonal antibodies. J Clin Endocrinol Metab 88:5537-5546.
17. Goede V, Schmidt T, Kimmina S, Kozian D, Augustin HG. 1998. Analysis of blood vessel maturation processes during cyclic ovarian angiogenesis. Lab Invest 78:1385-1394.
18. Hazzard TM, Molskness TA, Chaffin CL, Stouffer RL. 1999. Vascular endothelial growth factor (VEGF) and angiopoietin regulation by gonadotrophin and steroids in macaque granulosa cells during the peri-ovulatory interval. Mol Hum Reprod 5:1115-1121.
19. Herr D, Keck C, Tempfer C, Pietrowski D. 2004. Chorionic gonadotropin regulates the transcript level of VHL, p53, and HIF-2alpha in human granulosa lutein cells. Mol Reprod Dev 69:397-401.
20. Herrlich A, Kuhn B, Grosse R, Schmid A, Schultz G, Gudermann T. 1996. Involvement of Gs and Gi proteins in dual coupling of the luteinizing hormone receptor to adenylyl cyclase and phospholipase C. J Biol Chem 271:16764-16772.
21. Korff T, Augustin HG. 1998. Integration of endothelial cells in multicellular spheroids prevents apoptosis and induces differentiation. J Cell Biol 143:1341-1352.
22. Korff T, Kimmina S, Martiny-Baron G, Augustin HG. 2001. Blood vessel maturation in a 3-dimensional spheroidal coculture model: Direct contact with smooth muscle cells regulates endothelial cell quiescence and abrogates VEGF responsiveness. FASEB J 15:447-457.
23. Korpelainen EI, Alitalo K. 1998. Signaling angiogenesis and lymphangiogenesis. Curr Opin Cell Biol 10:159-164.
24. Muller T, Gromoll J, Simoni M. 2003. Absence of exon 10 of the human luteinizing hormone (LH) receptor impairs LH, but not human chorionic gonadotropin action. J Clin Endocrinol Metab 88:2242-2249.
25. Neill JD, Johansson ED, Knobil E. 1969. Patterns of circulating progesterone concentrations during the fertile menstrual cycle and the remainder of gestation in the rhesus monkey. Endocrinology 84:45-48.
26. Neulen J, Yan Z, Raczek S, Weindel K, Keck C, Weich HA, Marme D, Breckwoldt M. 1995. Human chorionic gonadotropin-dependent expression of vascular endothelial growth factor/vascular permeability factor in human granulosa cells: Importance in ovarian hyperstimulation syndrome. J Clin Endocrinol Metab 80:1967-1971.
27. Niswender GD, Juengel JL, Silva PJ, Rollyson MK, McIntush EW. 2000. Mechanisms controlling the function and life span of the corpus luteum. Physiol Rev 80:1-29.
28. Pietrowski D, Keck C. 2004. Differential regulation of ANG2 and VEGF-A in human granulosa lutein cells by choriogonadotropin. Exp Clin Endocrinol Diabetes 112:208-214.
29. Plendl J. 2000. Angiogenesis and vascular regression in the ovary. Anat Histol Embryol 29:257-266.
30. Reynolds LP, Grazul-Bilska AT, Redmer DA. 2000. Angiogenesis in the corpus luteum. Endocrine 12:1-9.
31. Ricke WA, Redmer DA, Reynolds LP. 1999. Growth and cellular proliferation of pig corpora lutea throughout the oestrous cycle. J Reprod Fertil 117:369-377.
32. Risau W. 1997. Mechanisms of angiogenesis. Nature 386:671-674.
33. Schiffenbauer YS, Abramovitch R, Meir G, Nevo N, Holzinger M, Itin A, Keshet E, Neeman M. 1997. Loss of ovarian function promotes angiogenesis in human ovarian carcinoma. Proc Natl Acad Sci USA 94:13203-13208.
34. Shweiki D, Neeman M, Itin A, Keshet E. 1995. Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: Implications for tumor angiogenesis. Proc Natl Acad Sci USA 92:768-772.
35. Spanel-Borowski K, Ricken AM, Saxer M, Huber PR. 1994. Long-term co-culture of bovine granulosa cells with microvascular endothelial cells: Effect on cell growth and cell death. Mol Cell Endocrinol 104:11-19.
36. Vajkoczy P, Farhadi M, Gaumann A, Heidenreich R, Erber R, Wunder A, Tonn JC, Menger MD, Breier G. 2002. Microtumor growth initiates angiogenic sprouting with simultaneous expression of VEGF, VEGF receptor-2, and angiopoietin-2. J Clin Invest 109:777-785.
37. Witt PS, Pietrowski D, Keck C. 2004. PKA- and PKC-dependent regulation of angiopoietin 2 mRNA in human granulosa lutein cells. Horm Metab Res 36:82-85.
38. Wulff C, Dickson SE, Duncan WC, Fraser HM. 2001. Angiogenesis in the human corpus luteum: Simulated early pregnancy by HCG treatment is associated with both angiogenesis and vessel stabilization. Hum Reprod 16:2515-2524.
39. Yan Z, Neulen J, Raczek S, Weich HA, Keck C, Grunwald K, Breckwoldt M. 1998. Vascular endothelial growth factor (VEGF)/vascular permeability factor (VPF) production by luteinized human granulosa cells in vitro; a paracrine signal in corpus luteum formation. Gynecol Endocrinol 12:149-153.
40. Zeleznik AJ. 1998. In vivo responses of the primate corpus luteum to luteinizing hormone and chorionic gonadotropin. Proc Natl Acad Sci USA 95:11002-11007.
41. Zygmunt M, Herr F, Keller-Schoenwetter S, Kunzi-Rapp K, Munstedt K, Rao CV, Lang U, Preissner KT. 2002. Characterization of human chorionic gonadotropin as a novel angiogenic factor. J Clin Endocrinol Metab 87:5290-5296.